WHO ICTRP trial

Effects of fish oil supplementation on neural activity, cardiovascular…

ACTRN12610000616077 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting

Key facts

Trial ID ACTRN12610000616077
Public title Effects of fish oil supplementation on neural activity, cardiovascular functioning and cognitive performance
Scientific title Effects of fish oil on brain efficiency in a healthy adult population and in a population of adults presenting with Attention Deficit Hyperactivity Disorder (ADHD) symptoms
Primary sponsor Australian Research Council
Secondary sponsors Swinburne University of Technology
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Long chain n-3 fatty acids intake and ADHD;omega-3 fatty acids and cardiovascular functioning;omega-3 fatty acids and neural activity/cognitive performance; Long chain n-3 fatty acids intake and ADHD omega-3 fatty acids and cardiovascular…
Interventions A group of 60 healthy volunteers and a population of 60 adults with ADHD will be randomly distributed into three diet groups and will be given 4 capsules a day of either an eicosapentaenoic omega-3 fatty acid (EPA)-rich diet (containing…
Registration date Jul 28, 2010
Target size 120
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations